Floatz logo

Naltrexone

Blood Pressure

National and Kapodistrian University of AthensSmall moleculePhase 4 / ApprovedDormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

13 Active assets in the Blood Pressure cohort.

Asset / SponsorPhaseRating
Hydrochlorothiazide
Yuhan Corporation
Phase 4BBB
LABETALOL
ProMedica Health System
Phase 3BB
VALSARTAN
ARKAY Therapeutics
Phase 4BB
Glibenclamide
University of Campinas, Brazil
Phase 4BB
Phentermine
VIVUS LLC
Phase 4BB

View all 33 →

Same molecule, other indications

Naltrexone is also rated in:

alcohol dependenceDormant
BBB
Indicative ·
79 / 100
View asset →
nicotine dependenceDormant
BBB
Indicative ·
76 / 100
View asset →
osteoarthritisDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →